Britain could be getting high on the benefits of a full-scale medical cannabis industry James Short One in five of the world’s best-selling prescription drugs are developed in Britain. And, with the legalisation of medical cannabis in 2018, the UK has an opportunity to capitalise on a new market. But while the regulatory framework is being developed, and patient studies are underway, there is a significant way to go to deliver [...]
